Purchase of assorted proteins and small molecules - brand name only
Closed Solicitation Posted
- Solicitation number
- 75N95021Q00082
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Place of performance
- MN 55413 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This combined synopsis and solicitation issued by the National Institute on Drug Abuse on behalf of the National Center for Advancing Translational Sciences seeks the non-competitive purchase of 89 items, including 27 different recombinant human proteins and 12 types of small molecules, from R&D Systems, Inc. Delivery within 14 days of order receipt is required to NCATS in Rockville, Maryland. Responses are due by May 5, 2021 and shall be submitted via email to the contracting officer.
No set-aside is designated for this acquisition. As the proteins and small molecules from R&D Systems, Inc. are stocked by NCATS to maintain consistent cell growth and viability across research projects, and re-optimization of assays would be required if an alternate supplier was used, this acquisition is being conducted on a non-competitive basis under FAR Subpart 13.5. The place of performance is Minneapolis, Minnesota where R&D Systems, Inc. is located. The anticipated award date is May 7, 2021.
Notice text
Non-competitive purchase of assorted proteins and small molecules from R&D Systems, Inc., 614 McKinley Place NW,Minneapolis,MN 55413 for the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, in accordance with the attached combined synopsis/solicitation.
Files
| File | Type | Posted |
|---|---|---|
| D.5936116 CSS noncompetitive.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| NOI - B2B Award entitled - Developing Red Cell-Sp | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - 4D-Nucleofector Core Unit and X Unit | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity